Myopathy in Zidovudine Treated HIV Infection

J Gordon Millichap

doi:10.15844/pedneurbriefs-5-8-2

Myopathy in Zidovudine Treated HIV Infection

Pediatric Neurology Briefs

Volume 5 (1991): Issue 8

By: J Gordon Millichap

Open Access

|Aug 1991

Abstract

Elevations in serum CK levels in 80% of 87 children enrolled in a multi-centered trial of oral zidovudine treatment for symptomatic HIV infection are reported from the Department of Pediatrics, University Medical Center, Durham, NC.

References

Walter EB Drucker RP McKinney RE Wilfert CM Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy J Pediatr 1991 Jul 119 1 Pt 1 152 5 1906098 10.1016/S0022-3476(05)81057-1
Open DOI Search in Google Scholar Back to article
Blanche S Duliege AM Navarette MS Tardieu M Debré M Rouzioux C Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period Pediatrics 1991 Aug 88 2 364 70 1861941
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-5-8-2 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 58 - 59

Published on: Aug 1, 1991

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Non-Inflammatory Myopathy,

Proximal Muscle,

Electron Microscopy

© 1991 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 5 (1991): Issue 8